167 related articles for article (PubMed ID: 38484271)
1. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
Ozerturk S; Derici Yildirim D; Arikoglu T; Kuyucu S; Kont Ozhan A
Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):22-32. PubMed ID: 38484271
[No Abstract] [Full Text] [Related]
2. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
6. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
[TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.
Antoon JW; Goldman JL; Shah SS; Lee B
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of mortality risk and immunosuppressive therapy for Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome using the TriNetX research network.
Ozhathil DK; Powell CM; Corley CV; Golovko G; Song J; El Ayadi A; Wolf SE; Kahn SA
Burns; 2024 Feb; 50(1):75-86. PubMed ID: 37734977
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.
Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y
Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management.
Frantz R; Huang S; Are A; Motaparthi K
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577817
[TBL] [Abstract][Full Text] [Related]
14. Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis.
Tsai TY; Huang IH; Chao YC; Li H; Hsieh TS; Wang HH; Huang YT; Chen CY; Cheng YC; Kuo PH; Huang YC; Tu YK
J Am Acad Dermatol; 2021 Feb; 84(2):390-397. PubMed ID: 32898587
[TBL] [Abstract][Full Text] [Related]
15. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
Mittmann N; Chan B; Knowles S; Cosentino L; Shear N
Am J Clin Dermatol; 2006; 7(6):359-68. PubMed ID: 17173470
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Miyamoto Y; Ohbe H; Kumazawa R; Matsui H; Fushimi K; Yasunaga H; Ohta B
JAMA Dermatol; 2023 May; 159(5):481-487. PubMed ID: 36884227
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children.
Koh MJ; Tay YK
J Am Acad Dermatol; 2010 Jan; 62(1):54-60. PubMed ID: 19811851
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.
Ye LP; Zhang C; Zhu QX
PLoS One; 2016; 11(11):e0167120. PubMed ID: 27902746
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
